Clinical trials: Superficial Thrombophlebitis
Venous Insufficiency
Preventing the Development of Venous Insufficiency in Pregnant Women Through Use of Compression Stockings
Problem: Approximately 4 million live births occur in the United States each year. Pregnancy causes many physical changes in the mother, including venous distension, increased ability to form blood clots, and hormonal changes.
- Trial name
- NCT01793194
- Testing
- Compression Stockings
- Where
- United States
- Volunteers
- 44 people
- Sponsor
- Johns Hopkins University
Thrombosis, Venous
Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)
To evaluate fondaparinux 2.5mg subcutaneously once daily for 45 days in the treatment of acute (recent) superficial thrombophlebitis.
- Trial name
- NCT00443053
- Where
- 227 sites in Bulgaria, Czechia and 15 more
- Volunteers
- 3,002 people
- Sponsor
- GlaxoSmithKline
Superficial Vein Thrombosis, Endovenous Laser Ablation
Endovenous Laser Ablation in Acute Thrombophlebitis of the Varicose Great Saphenous Vein
Рrospective single-centre randomized open-label study for comparison three modes of treatment for thrombosis of varicose great saphena vein - standard medical with fondaparinux sodium for 45 days, endovenous laser ablation close…
- Trial name
- NCT05001776
- Testing
- Endovenous laser ablation, Fondaparinux Sodium
- Where
- Russia
- Volunteers
- 105 people
- Sponsor
- National Medical Research Center for Therapy and Preventive Medicine
Superficial Thrombophlebitis, Upper Extremity Superficial Thrombophlebitis
Management of Superficial Thrombophlebitis
The purpose of this study is to test the hypothesis that Fragmin (dalteparin sodium) subcutaneously once daily for 7 days is more effective than Ibuprofen given orally three times daily for 7 days for the treatment of superficial…
- Conditions
- Superficial Thrombophlebitis, Upper Extremity Superficial Thrombophlebitis, Lower Extremity Superficial Thrombophlebitis
- Trial name
- NCT00264381
- Testing
- Dalteparin sodium injection
- Where
- 2 sites in United States
- Volunteers
- 72 people
- Sponsor
- University of Oklahoma
Superficial Thrombophlebitis
Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis
The aim of the study is to establish whether treatment of superficial vein thrombosis (SVT) with low-molecular-weight heparin in preventive or therapeutic doses prevents disease progression and thromboembolic events (deep vein…
- Trial name
- REVETR (NCT01245998)
- Testing
- Dalteparin
- Where
- Slovenia
- Volunteers
- 68 people
- Sponsor
- University Medical Centre Ljubljana
Catheter Infection, Catheter Thrombosis
Midlines and Thrombophlebitis
Peripherally inserted central catheters (PICCs) are central catheters that are placed via peripheral vein under ultrasound guidance and may be used for patients with difficult venous access for long-term central or peripheral…
- Conditions
- Catheter Infection, Catheter Thrombosis, Catheter Complications
- Trial name
- NCT03725293
- Testing
- Angiodynamics BioFlo Midline Catheter, Teleflex Arrowg+ard Blue Advanced Midline Catheter
- Where
- United States
- Volunteers
- 212 people
- Sponsor
- Corewell Health East
Thrombosis
Venous Vascularization and Inflammation on Contrast-enhanced Ultrasound (CEUS) in Patients With Thrombosis
Background: Contrast-enhanced ultrasound (CEUS) visualization of the adventitial vasa vasorum. Late phase CEUS detect inflammation by visualizing microbubbles phagocytosed by monocytes.
- Trial name
- NCT01367769
- Testing
- No intervention
- Where
- Switzerland
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- University Hospital, Basel, Switzerland
Varicose Veins
Evaluation of Endovenous Sclerotherapy for Treatment of Varicose Veins
The overall objective will be to evaluate clinical predictors of outcomes in patients who undergo endovenous sclerotherapy for the treatment of varicose veins.
- Trial name
- NCT00954980
- Where
- United States
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- University of Oklahoma
Deep Vein Thrombosis, Superficial Thrombophlebitis
DOACT Algorithm Versus AI-Based Decision Models in Oral Anticoagulant Therapy for Vascular Patients
Study using a decision algorithm for the application of an oral anticoagulant calculator in vascular diseases, aimed at validating a clinical decision-support tool for conditions such as deep vein thrombosis, superficial…
- Conditions
- Deep Vein Thrombosis, Superficial Thrombophlebitis, Pulmonary Thromboembolisms, Clinical Decision Support Systems
- Trial name
- DOACT (NCT07290608)
- Testing
- DOACT algorithm, No algorithm, LLM-based tools
- Where
- Brazil
- Volunteers
- 59 people, healthy volunteers welcome
- Sponsor
- ITALO EUGENIO SOUZA GADELHA DE ABREU
Thrombophlebitis
Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in Superficial Vein Thrombosis
The optimal treatment of superficial venous thrombosis (SVT) is still uncertain. Though low molecular weight heparin (LMWH) is considered the treatment of choice, studies conducted so far do not give clear indications of the…
- Trial name
- NCT00362947
- Testing
- LMWH parnaparin subcutaneously
- Where
- 2 sites in Italy
- Volunteers
- 664 people
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
Thrombophlebitis
POST (Prospective Observational Superfial Thrombophlebitis)
We performed a national cross-sectional and prospective large epidemiological cohort study in patients with ST. Office- and hospital-based vascular medicine French practitioners enrolled all consecutive patients with a…
- Trial name
- POST (NCT00818688)
- Testing
- compression ultrasonography at 3 months
- Where
- 5 sites in France
- Volunteers
- 844 people
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
Superficial Thrombophlebitis of the Upper Limb
Topical Diclofenac Gel in Patients With Superficial Inflammation of the Veins
This study will assess the efficacy, safety and tolerability of topically administered diclofenac gel versus placebo with respect to the symptom score (pain, temperature and size of erythema along the superficial vein)
- Trial name
- NCT00377806
- Testing
- Diclofenac gel
- Where
- Germany
- Volunteers
- 200 people
- Sponsor
- Novartis
Chronic Venous Insufficiency, Varicose Vein
Efficacy and Safety of Esarin Gel in Chronic Venous Insufficiency and Varicose Veins
Evaluation efficacy and safety of Esarin Gel in subjects with chronic venous insufficiency or varicose veins combine superficial vein thrombophlebitis.
- Conditions
- Chronic Venous Insufficiency, Varicose Vein, Superficial Vein Thrombophlebitis
- Trial name
- NCT02346058
- Testing
- Esarin Gel
- Where
- Taiwan
- Volunteers
- 53 people
- Sponsor
- Ten Sun Pharma Company Limited
Thrombophlebitis, Phlebitis
Efficacy and Tolerability of Hirudoid Cream in Prophylaxis and Treatment Infusion Phlebitis
Patients receiving nutritional emulsion for at least 3 days will be treated with Hirudoid cream or placebo cream to prevent and treat phlebitis caused by the infusion.
- Trial name
- NCT01943006
- Testing
- Hirudoid cream 0.3 % Mucopolysaccharide polysulfate
- Where
- 4 sites in Thailand
- Volunteers
- 144 people
- Sponsor
- Medinova AG